PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10200322-2	1999	Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh.	Bleomycin	0-9	bleomycin hydrolase	Mus musculus	92-96	
10200322-2	1999	Bleomycin (BLM), a clinically used glycopeptide anticancer agent, is deaminated in vitro by Blmh.	Bleomycin	11-14	bleomycin hydrolase	Mus musculus	92-96	
2451525-3	1988	Protection of lung tissue from bleomycin-induced toxicity may occur through both specific metabolic inactivation of bleomycin by the enzyme bleomycin hydrolase, as well as by such non-specific antioxidants as catalase and the glutathione system.	Bleomycin	31-40	bleomycin hydrolase	Mus musculus	140-159	
2451525-3	1988	Protection of lung tissue from bleomycin-induced toxicity may occur through both specific metabolic inactivation of bleomycin by the enzyme bleomycin hydrolase, as well as by such non-specific antioxidants as catalase and the glutathione system.	Bleomycin	116-125	bleomycin hydrolase	Mus musculus	140-159